This Lung and cardiovascular Development and Disease Pathogenesis Training Program grant aims to provide advanced research training by supporting stipends for three pre-doctoral and for three post-doctoral candidates within the University of Cincinnati Graduate Programs. The training environment draws heavily upon established, integrated, innovative Graduate Programs focused to molecular, developmental, and cell biology research and benefits from related, NHLBI-supported research programs. The program brings together 30 distinguished, NIH-funded investigators experienced in using modern molecular, cellular, and gene targeting and transfer strategies to study the developmental biology of the lungs, heart, and blood and pathogenesis-based diagnostic and therapeutic discovery at Cincinnati Children's Medical Center and the University of Cincinnati College of Medicine. Program faculty have shared research interests and a long history of collaboration in basic and translational research. Major research themes include pathogenesis of pulmonary and cardiac disorders, gene expression, function, and regulation during lung development, injury, and repair, and development and evaluation of novel biomarkers, diagnostics, and therapies for lung diseases. Promising trainees engaged in pre- or post-doctoral training programs will be identified, recruited, and selected on a competitive basis. Pre-doctoral trainees will obtain their PhD degrees in either the Graduate Program in Developmental Biology, Immunobiology, Biomedical Sciences, or Pathobiology and Molecular Medicine;or the Department of Anatomy and Cell Biology, Molecular Genetics, or Biochemistry and Microbiology at the University of Cincinnati College of Medicine. Post-doctoral trainees may have an MD or PhD degree, or both. Special attention will be given to recruitment of minority individuals and candidates with an MD degree. Research training will include mentoring, career development, training in the responsible conduct of research, a course in Ethics in Research, research presentation skill development (all required), and various optional seminars and courses within the graduate programs in which training faculty participate. Two broad training focus areas are available: 1) pulmonary and cardiovascular development, injury and repair, and 2) pathogenesis-based lung and cardiovascular disease biomarkers, diagnostic, and therapeutics development. Trainees will attend regular research meetings and several pertinent seminar series. Program Administration will include the Principal Investigator, two Co-Principal Investigators, an Executive Committee, and External and internal Advisory Committees. The progress of each trainee, quality of mentors, and overall effectiveness of the program will be critically reviewed annually. Trainees will meet with their Mentor regularly, the Program Director twice yearly, and their Mentoring Committee annually. This T32 renewal application (Years 21-25) will permit us to continue a program with outstanding productivity in preparing new investigators with enhanced research training and competence in critical aspects of lung development and disease pathogenesis.
This renewal T32 grant application for a Lung and Cardiovascular Development and Disease Pathogenesis Training Program will continue support to recruit and train outstanding pre-doctoral and post-doctoral candidates, preparing them to advance discoveries that improve the diagnosis and treatment of lung diseases and to become the future research leaders in pulmonary research and medicine. This Program meets a critical national need to increase the quantity and quality of young investigators who can apply cellular, molecular, and genetic strategies to the study of lung, heart, and blood disorders. There is an ever-increasing loss of M.D. and Ph.D. candidates from academic-scientific careers at a time in which unparalleled opportunities exist to identify mechanisms of disease and to develop novel biomarkers, diagnostics, and treatment strategies to improve human health.
|Thomen, Robert P; Walkup, Laura L; Roach, David J et al. (2016) Hyperpolarized (129)Xe for investigation of mild cystic fibrosis lung disease in pediatric patients. J Cyst Fibros :|
|Higano, Nara S; Hahn, Andrew D; Tkach, Jean A et al. (2016) Retrospective respiratory self-gating and removal of bulk motion in pulmonary UTE MRI of neonates and adults. Magn Reson Med :|
|Davis, Benjamin P; Rothenberg, Marc E (2016) Mechanisms of Disease of Eosinophilic Esophagitis. Annu Rev Pathol 11:365-93|
|Stein, Jill M; Walkup, Laura L; Brody, Alan S et al. (2016) Quantitative CT characterization of pediatric lung development using routine clinical imaging. Pediatr Radiol 46:1804-1812|
|Schwanekamp, Jennifer A; Lorts, Angela; Vagnozzi, Ronald J et al. (2016) Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling. Arterioscler Thromb Vasc Biol 36:60-8|
|Chung, Eunah; Deacon, Patrick; Marable, Sierra et al. (2016) Notch signaling promotes nephrogenesis by downregulating Six2. Development 143:3907-3913|
|Verma, A H; Bueter, C L; Rothenberg, M E et al. (2016) Eosinophils subvert host resistance to an intracellular pathogen by instigating non-protective IL-4 in CCR2(-/-) mice. Mucosal Immunol :|
|Walkup, Laura L; Thomen, Robert P; Akinyi, Teckla G et al. (2016) Feasibility, tolerability and safety of pediatric hyperpolarized (129)Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis. Pediatr Radiol 46:1651-1662|
|Wagh, Purnima K; Gardner, Margaret A; Ma, Xiaolan et al. (2015) Cell- and developmental stage-specific Dicer1 ablation in the lung epithelium models cystic pleuropulmonary blastoma. J Pathol 236:41-52|
|Craig, Michael P; Grajevskaja, Viktorija; Liao, Hsin-Kai et al. (2015) Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 35:865-76|
Showing the most recent 10 out of 44 publications